These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 4006340)

  • 1. Evaluation of flecainide acetate in rapid atrial fibrillation complicating Wolff-Parkinson-White syndrome.
    Kappenberger LJ; Fromer MA; Shenasa M; Gloor HO
    Clin Cardiol; 1985 Jun; 8(6):321-6. PubMed ID: 4006340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of flecainide on electrophysiological properties of accessory pathways in the Wolff-Parkinson-White syndrome.
    Neuss H; Buss J; Schlepper M; Berthold R; Mitrović V; Krämer A; Musial WJ
    Eur Heart J; 1983 May; 4(5):347-53. PubMed ID: 6617681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome.
    Kasper W; Treese N; Meinertz T; Jähnchen E; Pop T
    Am J Cardiol; 1983 Jun; 51(10):1618-22. PubMed ID: 6858867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ; Nathan AW; Bexton RS; Spurrell RA; Camm AJ
    Am J Cardiol; 1983 Mar; 51(5):770-6. PubMed ID: 6829436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of efficacy of flecainide in the Wolff-Parkinson-White syndrome after isoproterenol administration.
    Brembilla-Perrot B; Admant P; Le Helloco A; Pernot C
    Eur Heart J; 1985 Dec; 6(12):1074-8. PubMed ID: 3830711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of flecainide in supraventricular arrhythmias].
    Chouty F; Leclercq JF; Coumel P
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):237-41. PubMed ID: 3740779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
    Chen SA; Chiang CE; Tai CT; Lee SH; Chiou CW; Ueng KC; Wen ZC; Cheng CC; Chang MS
    Circulation; 1996 Jun; 93(11):2023-32. PubMed ID: 8640978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flecainide in the Wolff-Parkinson-White syndrome.
    Crozier I
    Am J Cardiol; 1992 Aug; 70(5):26A-32A. PubMed ID: 1509995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible protective effect of propafenone or flecainide during atrial fibrillation in patients with an accessory atrioventricular connection.
    Auricchio A
    Am Heart J; 1992 Oct; 124(4):932-7. PubMed ID: 1529904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
    Prystowsky EN; Klein GJ; Rinkenberger RL; Heger JJ; Naccarelli GV; Zipes DP
    Circulation; 1984 Feb; 69(2):278-87. PubMed ID: 6418407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Administration of adenosine for termination of atrioventricular nodal reentry tachycardia: induction of atrial fibrillation with rapid conduction over an accessory pathway and unmasking of concomitant Wolff-Parkinson-White syndrome].
    Drescher S; Bosch RF; Mewis C; Kühlkamp V
    Z Kardiol; 2000 Jun; 89(6):522-6. PubMed ID: 10929437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of flecainide on atrial electrophysiology in the Wolff-Parkinson-White syndrome.
    Camm AJ; Katritsis D; Nunain SO
    Am J Cardiol; 1992 Aug; 70(5):33A-37A. PubMed ID: 1509996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome.
    O'Nunain S; Garratt CJ; Linker NJ; Gill J; Ward DE; Camm AJ
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):2028-34. PubMed ID: 1721219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Ludmer PL; McGowan NE; Antman EM; Friedman PL
    J Am Coll Cardiol; 1987 Jun; 9(6):1357-63. PubMed ID: 3294970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of transesophageal auricular stimulation for evaluating the accessory pathway and effect of treatment in Wolf-Parkinson-White syndrome].
    Kieny JR; Kraenner C; Facello A; Roul G; Mossard JM; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1585-93. PubMed ID: 2510679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of flecainide acetate for refractory junctional tachycardias in children with the Wolff-Parkinson-White syndrome.
    Ward DE; Jones S; Shinebourne EA
    Am J Cardiol; 1986 Apr; 57(10):787-90. PubMed ID: 3962866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
    Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
    Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of the anti-arrhythmia agent ethmozin on the refractory period of the accessory pathway in Wolff-Parkinson-White syndrome].
    Rakovec P; Kenda MF
    Wien Med Wochenschr; 1986 Feb; 136(3):65-6. PubMed ID: 3515775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation in patients with an accessory pathway: importance of the conduction properties of the accessory pathway.
    Della Bella P; Brugada P; Talajic M; Lemery R; Torner P; Lezaun R; Dugernier T; Wellens HJ
    J Am Coll Cardiol; 1991 May; 17(6):1352-6. PubMed ID: 2016453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.